Denise Karen Reinke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Michigan-Ann ArborMasters, 2000
Publications & Presentations
PubMed
- 806 citationsPembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trialHussein Abdul-Hassan Tawbi, Melissa Amber Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze
The Lancet. Oncology. 2017-11-01 - 188 citationsDoxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multi...William D. Tap, Zsuzsanna Papai, Brian A. Van Tine, Steven Attia, Kristen N. Ganjoo
The Lancet. Oncology. 2017-08-01 - 8 citationsSubgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial.Eugenie Younger, Karla V. Ballman, Yao Lu, Zsuzsanna Papai, Brian A. Van Tine
Journal of Geriatric Oncology. 2018-06-01
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-355-3767
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
